Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS

Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors eva...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesiology (Philadelphia) 1999-12, Vol.91 (6), p.1577-1586
Hauptverfasser: ULLRICH, R, LORBER, C, RÖDER, G, URAK, G, FARYNIAK, B, SLADEN, R. N, GERMANN, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1586
container_issue 6
container_start_page 1577
container_title Anesthesiology (Philadelphia)
container_volume 91
creator ULLRICH, R
LORBER, C
RÖDER, G
URAK, G
FARYNIAK, B
SLADEN, R. N
GERMANN, P
description Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm. During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure < 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation. The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6. The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation.
doi_str_mv 10.1097/00000542-199912000-00007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69354924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69354924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-7d6fda0a135f43af5bc137be03304a8b11ba9d3cdb0cca5f186db1429b30fb023</originalsourceid><addsrcrecordid>eNpNkdtq3DAQhkVISbZpXiHoooQU4kYHa21dhm16gJRA2l6b0SmrYluupKW7z9SXrJzdHnQjZvj-f0b6EcKUvKVENjdkPqJmFZVSUlaKau40R2hBBWsrShtxjBalxStOGDtFL1P6PhOCtyfolBIhWyGbBfq1CmOOoe-tweDjT9jhKdqUNtHivLYRpt01Hn2OXuOw9cZiP66hh-zDeF3QMFo8heT3NYwG222OoEOcQrTQ48EOKkKhwnb3ZMdnIb66W31-eIMhYR2GqXiMOeHgir7YZ_sUIc_7TMUf9BrngG8f3315hV446JM9P9xn6Nv7u6-rj9X9w4dPq9v7SnNJctWYpTNAgHLhag5OKE15oyzhnNTQKkoVSMO1UURrEI62S6NozaTixCnC-Bm63PuW8T82NuVu8Enbvi_PCJvULSUXtWR1Ads9qGNIKVrXTdEPEHcdJd0cVPcnqO5vUM-tpkgvDjM2arDmP-E-mQK8PgCQNPSu_KH26R_HCKeU89-PBJ7i</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69354924</pqid></control><display><type>article</type><title>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>ULLRICH, R ; LORBER, C ; RÖDER, G ; URAK, G ; FARYNIAK, B ; SLADEN, R. N ; GERMANN, P</creator><creatorcontrib>ULLRICH, R ; LORBER, C ; RÖDER, G ; URAK, G ; FARYNIAK, B ; SLADEN, R. N ; GERMANN, P</creatorcontrib><description>Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm. During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure &lt; 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation. The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6. The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-199912000-00007</identifier><identifier>PMID: 10598597</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Administration, Inhalation ; Adolescent ; Adult ; Aged ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; APACHE ; Biological and medical sciences ; Child ; Combined Modality Therapy ; Electrocardiography ; Emergency and intensive respiratory care ; Extracorporeal Membrane Oxygenation ; Female ; Humans ; Intensive care medicine ; Male ; Medical sciences ; Middle Aged ; Nitric Oxide - administration &amp; dosage ; Nitric Oxide - therapeutic use ; Prone Position - physiology ; Respiration, Artificial ; Respiratory Distress Syndrome, Adult - physiopathology ; Respiratory Distress Syndrome, Adult - therapy ; Respiratory Function Tests ; Survival Analysis</subject><ispartof>Anesthesiology (Philadelphia), 1999-12, Vol.91 (6), p.1577-1586</ispartof><rights>2000 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-7d6fda0a135f43af5bc137be03304a8b11ba9d3cdb0cca5f186db1429b30fb023</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=1203113$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10598597$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>ULLRICH, R</creatorcontrib><creatorcontrib>LORBER, C</creatorcontrib><creatorcontrib>RÖDER, G</creatorcontrib><creatorcontrib>URAK, G</creatorcontrib><creatorcontrib>FARYNIAK, B</creatorcontrib><creatorcontrib>SLADEN, R. N</creatorcontrib><creatorcontrib>GERMANN, P</creatorcontrib><title>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm. During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure &lt; 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation. The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6. The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation.</description><subject>Administration, Inhalation</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>APACHE</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Combined Modality Therapy</subject><subject>Electrocardiography</subject><subject>Emergency and intensive respiratory care</subject><subject>Extracorporeal Membrane Oxygenation</subject><subject>Female</subject><subject>Humans</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nitric Oxide - administration &amp; dosage</subject><subject>Nitric Oxide - therapeutic use</subject><subject>Prone Position - physiology</subject><subject>Respiration, Artificial</subject><subject>Respiratory Distress Syndrome, Adult - physiopathology</subject><subject>Respiratory Distress Syndrome, Adult - therapy</subject><subject>Respiratory Function Tests</subject><subject>Survival Analysis</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkdtq3DAQhkVISbZpXiHoooQU4kYHa21dhm16gJRA2l6b0SmrYluupKW7z9SXrJzdHnQjZvj-f0b6EcKUvKVENjdkPqJmFZVSUlaKau40R2hBBWsrShtxjBalxStOGDtFL1P6PhOCtyfolBIhWyGbBfq1CmOOoe-tweDjT9jhKdqUNtHivLYRpt01Hn2OXuOw9cZiP66hh-zDeF3QMFo8heT3NYwG222OoEOcQrTQ48EOKkKhwnb3ZMdnIb66W31-eIMhYR2GqXiMOeHgir7YZ_sUIc_7TMUf9BrngG8f3315hV446JM9P9xn6Nv7u6-rj9X9w4dPq9v7SnNJctWYpTNAgHLhag5OKE15oyzhnNTQKkoVSMO1UURrEI62S6NozaTixCnC-Bm63PuW8T82NuVu8Enbvi_PCJvULSUXtWR1Ads9qGNIKVrXTdEPEHcdJd0cVPcnqO5vUM-tpkgvDjM2arDmP-E-mQK8PgCQNPSu_KH26R_HCKeU89-PBJ7i</recordid><startdate>19991201</startdate><enddate>19991201</enddate><creator>ULLRICH, R</creator><creator>LORBER, C</creator><creator>RÖDER, G</creator><creator>URAK, G</creator><creator>FARYNIAK, B</creator><creator>SLADEN, R. N</creator><creator>GERMANN, P</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19991201</creationdate><title>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</title><author>ULLRICH, R ; LORBER, C ; RÖDER, G ; URAK, G ; FARYNIAK, B ; SLADEN, R. N ; GERMANN, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-7d6fda0a135f43af5bc137be03304a8b11ba9d3cdb0cca5f186db1429b30fb023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1999</creationdate><topic>Administration, Inhalation</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>APACHE</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Combined Modality Therapy</topic><topic>Electrocardiography</topic><topic>Emergency and intensive respiratory care</topic><topic>Extracorporeal Membrane Oxygenation</topic><topic>Female</topic><topic>Humans</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nitric Oxide - administration &amp; dosage</topic><topic>Nitric Oxide - therapeutic use</topic><topic>Prone Position - physiology</topic><topic>Respiration, Artificial</topic><topic>Respiratory Distress Syndrome, Adult - physiopathology</topic><topic>Respiratory Distress Syndrome, Adult - therapy</topic><topic>Respiratory Function Tests</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>ULLRICH, R</creatorcontrib><creatorcontrib>LORBER, C</creatorcontrib><creatorcontrib>RÖDER, G</creatorcontrib><creatorcontrib>URAK, G</creatorcontrib><creatorcontrib>FARYNIAK, B</creatorcontrib><creatorcontrib>SLADEN, R. N</creatorcontrib><creatorcontrib>GERMANN, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>ULLRICH, R</au><au>LORBER, C</au><au>RÖDER, G</au><au>URAK, G</au><au>FARYNIAK, B</au><au>SLADEN, R. N</au><au>GERMANN, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>1999-12-01</date><risdate>1999</risdate><volume>91</volume><issue>6</issue><spage>1577</spage><epage>1586</epage><pages>1577-1586</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>Recent years have seen the introduction of innovative additive therapies for acute respiratory distress syndrome. However, because there are no reliable predictors of response to a particular therapy, potential responders to a specific therapeutic intervention may be lost. Therefore, the authors evaluated the effect of a combined therapeutic approach on the survival of patients with acute respiratory distress syndrome, when treated according to a strict algorithm. During a 2.5-yr period, 84 patients with acute respiratory distress syndrome were assigned to a standardized treatment protocol. Data analysis was performed by retrospective review of patient charts. Patients were treated using a stepwise treatment algorithm of pressure-controlled ventilation (peak airway pressure &lt; 35 cm H2O), positive end-expiratory pressure (PEEP; 12-15 cm H2O), permissive hypercapnia, inhaled nitric oxide (5-20 ppm), and prone positioning. These interventions were termed "conventional therapy." Response to treatment was defined as a more than 20% increase in arterial oxygen tension (PaO2). Nonresponders were triaged to extracorporeal membrane oxygenation. The overall survival rate was 80%. All patients received conventional therapy up to 96 h; 71 responded to conventional therapy and 59 survived (83%). Thirteen patients (15%) did not respond to conventional therapy and underwent extracorporeal membrane oxygenation; 8 of these patients (62%) survived. For the group, the mean admission lung injury score was 3.3+/-0.5, the PaO2/fractional inspired oxygen tension (F(I)O2) ratio was 96+/-45, and the Acute Physiology and Chronic Health Evaluation (APACHE) II score was 18+/-6. The 80% overall survival rate achieved in this group of patients with severe acute respiratory distress syndrome may in part reflect the additive beneficial effects of combined treatment methods, such as airway pressure control, nitric oxide inhalation, prone position, and early triage of nonresponders to extracorporeal membrane oxygenation.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>10598597</pmid><doi>10.1097/00000542-199912000-00007</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0003-3022
ispartof Anesthesiology (Philadelphia), 1999-12, Vol.91 (6), p.1577-1586
issn 0003-3022
1528-1175
language eng
recordid cdi_proquest_miscellaneous_69354924
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Administration, Inhalation
Adolescent
Adult
Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
APACHE
Biological and medical sciences
Child
Combined Modality Therapy
Electrocardiography
Emergency and intensive respiratory care
Extracorporeal Membrane Oxygenation
Female
Humans
Intensive care medicine
Male
Medical sciences
Middle Aged
Nitric Oxide - administration & dosage
Nitric Oxide - therapeutic use
Prone Position - physiology
Respiration, Artificial
Respiratory Distress Syndrome, Adult - physiopathology
Respiratory Distress Syndrome, Adult - therapy
Respiratory Function Tests
Survival Analysis
title Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A47%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Controlled%20airway%20pressure%20therapy,%20nitric%20oxide%20inhalation,%20prone%20position,%20and%20extracorporeal%20membrane%20oxygenation%20(ECMO)%20as%20components%20of%20an%20integrated%20approach%20to%20ARDS&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=ULLRICH,%20R&rft.date=1999-12-01&rft.volume=91&rft.issue=6&rft.spage=1577&rft.epage=1586&rft.pages=1577-1586&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-199912000-00007&rft_dat=%3Cproquest_cross%3E69354924%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69354924&rft_id=info:pmid/10598597&rfr_iscdi=true